Nykode Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Total Funding:
36596103
Last Funding Type:
Venture Round
Estimated Revenue:
Less than $1M
Founded Date:
2007-01-01
Industry:
Tumor-Specific Antigens
Employee Number:
11-50
Last Funding Date:
2016-12-16
Funding Status:
Venture
Headquarters:
Oslo, Oslo, Norway
Investors Number:
5